Ionara Bio
Reprogramming Cardiac Healing. Preventing Heart Failure.
Targeting the critical days after a heart attack to promote healthy cardiac healing and prevent heart failure
Approximately 805,000 myocardial infarctions occur annually in the U.S., with nearly 20% of patients progressing to heart failure within five years. Current therapeutic regimens fail to address the pivotal 7-day post-infarction window, precisely when an exaggerated inflammatory cascade drives pathological myocardial fibrosis and scarring.
The Ionara Intervention
Ionara acts directly within this acute phase to intercept the cascade, blunting adverse ventricular remodeling and orchestrating functional cardiac tissue repair before permanent scarring occurs.
Ionara intervenes during this critical window to modulate cardiac repair, reduce adverse remodeling, and prevent progression to heart failure.
How TRPV2 inhibition works